Learning Objectives: At the conclusion of this presentation, participants will be able to:
: 1) Choose among available options for the management of women with an inherited predisposition towards breast and gynecologic cancer;
2) Discuss the utility of expanded panel testing in the evaluation of inherited cancer risk; and
3) Evaluate the role of alternative delivery models for providing cancer risk assessment.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation